Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway.

Front Immunol · 2022 · PMC9196078 · PMID 35711444

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Despite the limit of the small sample size of our cohort, a decreasing trend of both length of stay and time to negative molecular NPS in MoAb-treated vs. plasma-treated patients was observed.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.